5-hydroxymethylcytosine has been researched along with Syndrome, VKH (Vogt Koyanagi Harada) in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Q; Chen, Z; Deng, Y; Lai, Y; Liu, Y; Luo, X; Pu, Y; Su, G; Yang, P; Yi, K; Zhang, W; Zhang, Y | 1 |
1 other study(ies) available for 5-hydroxymethylcytosine and Syndrome, VKH (Vogt Koyanagi Harada)
| Article | Year |
|---|---|
TET2-mediated upregulation of 5-hydroxymethylcytosine in LRRC39 promoter promotes Th1 response in association with downregulated Treg response in Vogt-Koyanagi-Harada disease.
Topics: CD4-Positive T-Lymphocytes; Dioxygenases; DNA-Binding Proteins; Forkhead Transcription Factors; Humans; Interleukin-17; Promoter Regions, Genetic; RNA, Messenger; T-Lymphocytes, Regulatory; Up-Regulation; Uveomeningoencephalitic Syndrome | 2023 |